Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesTriple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide. A Randomized Clinical Trial
Hypertension, 05/27/09
Calhoun DA et al. - Significantly more patients on triple therapy achieved overall BP control and systolic and diastolic control compared with each dual therapy. Aml/Val/HCTZ was well tolerated. The benefits of triple therapy over dual therapy were observed regardless of age, sex, race, ethnicity, or baseline mean sitting systolic BP. This study demonstrates the efficacy/safety of treating moderate and severe hypertension with Aml/Val/HCTZ 10/320/25 mg.
Related Articles
Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients
Journal of Electrocardiology, 10/29/09
Relevance Score: 66%
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study
Journal of Hypertension, 10/26/09
Relevance Score: 66%
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
Circulation, 10/08/09
Relevance Score: 66%
FDA approves Twynsta a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours
Boehringer Ingelheim, 10/20/09
Relevance Score: 65%
Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study
American Journal of Cardiovascular Drugs, 10/07/09
Relevance Score: 65%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet, 11/30/09
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Vascular Health and Risk Management, 11/30/09
Vernakalant hydrochloride for the treatment of atrial fibrillation
Expert Opinion on Investigational Drugs, 11/30/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values
Journal of Hypertension, 11/30/09
The Role of Renal Sympathetic Nerves in Hypertension: Has Percutaneous Renal Denervation Refocused Attention on Their Clinical Significance
Progress in Cardiovascular Diseases , 11/30/09
Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure
Journal of Hypertension, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor